drugset
drugset / Trial / NCT00666900

A Clinical Study Evaluating the Safety and Efficacy of IDP-107 in Patients With Acne Vulgaris

NCT00666900 ↗

Phase 2 Completed 366 enrolled Dow Pharmaceutical Sciences
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to assess the safety and effectiveness of IDP-107 in treating patients with acne vulgaris.

Timeline

Start
2008-01
Primary completion
2009-03
Completion
2009-09

Drugs

EvaluationDrugModalityDoseRoute
Subject IDP-107 Unknown — —

Indications

acne